目次

Table of Contents

1 Executive Summary
1.1. Market value
1.2. Market value forecast
1.3. Geography segmentation
1.4. Market share
1.5. Market rivalry
1.6. Competitive Landscape

2 Market Overview
2.1. Market definition
2.2. Market analysis

3 Market Data
3.1. Market value

4 Market Segmentation
4.1. Geography segmentation

5 Market Outlook
5.1. Market value forecast

6 Five Forces Analysis
6.1. Summary
6.2. Buyer power
6.3. Supplier power
6.4. New entrants
6.5. Threat of substitutes
6.6. Degree of rivalry

7 Competitive Landscape
7.1. Market share
7.2. Who are the leading players?
7.3. What strategies do leading players follow?
7.4. What has been the rationale behind recent strategic partnerships?
7.5. Are there any threats towards leading players?

8 Company Profiles
8.1. Novartis AG
8.2. F. Hoffmann-La Roche Ltd
8.3. Bayer AG
8.4. Boehringer Ingelheim GmbH

9 Macroeconomic Indicators
9.1. Country data

10 Appendix
10.1. Methodology
10.2. Industry associations
10.3. Related MarketLine research
10.4. About MarketLine

List of Tables
Table 1: Germany pharmaceuticals market value: $ billion, 2016-21
Table 2: Germany pharmaceuticals market geography segmentation: $ billion, 2021
Table 3: Germany pharmaceuticals market value forecast: $ billion, 2021-26
Table 4: Germany pharmaceuticals market share: % share, by value, 2021
Table 5: Novartis AG: key facts
Table 6: Novartis AG: Annual Financial Ratios
Table 7: Novartis AG: Key Employees
Table 8: Novartis AG: Key Employees Continued
Table 9: F. Hoffmann-La Roche Ltd: key facts
Table 10: F. Hoffmann-La Roche Ltd: Annual Financial Ratios
Table 11: F. Hoffmann-La Roche Ltd: Key Employees
Table 12: Bayer AG: key facts
Table 13: Bayer AG: Annual Financial Ratios
Table 14: Bayer AG: Key Employees
Table 15: Bayer AG: Key Employees Continued
Table 16: Boehringer Ingelheim GmbH: key facts
Table 17: Boehringer Ingelheim GmbH: Key Employees
Table 18: Germany size of population (million), 2017-21
Table 19: Germany gdp (constant 2005 prices, $ billion), 2017-21
Table 20: Germany gdp (current prices, $ billion), 2017-21
Table 21: Germany inflation, 2017-21
Table 22: Germany consumer price index (absolute), 2017-21
Table 23: Germany exchange rate, 2017-21

List of Figures
Figure 1: Germany pharmaceuticals market value: $ billion, 2016-21
Figure 2: Germany pharmaceuticals market geography segmentation: % share, by value, 2021
Figure 3: Germany pharmaceuticals market value forecast: $ billion, 2021-26
Figure 4: Forces driving competition in the pharmaceuticals market in Germany, 2021
Figure 5: Drivers of buyer power in the pharmaceuticals market in Germany, 2021
Figure 6: Drivers of supplier power in the pharmaceuticals market in Germany, 2021
Figure 7: Factors influencing the likelihood of new entrants in the pharmaceuticals market in Germany, 2021
Figure 8: Factors influencing the threat of substitutes in the pharmaceuticals market in Germany, 2021
Figure 9: Drivers of degree of rivalry in the pharmaceuticals market in Germany, 2021
Figure 10: Germany pharmaceuticals market share: % share, by value, 2021